I

    IOBT (IOBT)

    Official site

    BIOTECHNOLOGY

    $0.05
    +0.00 (+0.00%)

    Last updated: Apr 07, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    56%(10/18)
    Avg Surprise
    -118.30%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Mar 31, 2026
    EPS Consensus$-0.16
    Range$-0.16 - $-0.16
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$0.00+100.0%
    60d ago$0.00+100.0%
    30d ago$0.00+100.0%
    7d ago$0.00+100.0%
    Current$-0.16
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Mar 26EST
    		-$-0.16---
    Dec 25
    Reported Mar 4
    		$0.00N/A+100.00%Beat+100.0%
    Sep 25
    Reported Nov 7
    		$-0.25$-0.34+27.59%Beat+30.6%
    Jun 25
    Reported Aug 14
    		$-0.40$-0.37-8.11%Miss-29.0%
    Mar 25
    Reported May 14
    		$-0.34$-0.31-9.68%Miss-13.3%
    Dec 24
    Reported Mar 27
    		$-0.48$-0.31-53.60%Miss-20.0%
    Sep 24
    Reported Nov 12
    		$-0.36$-0.29-24.14%Miss+16.3%
    Jun 24
    Reported Aug 13
    		$-0.31$-0.34+8.82%Beat+58.1%
    Mar 24
    Reported May 14
    		$-0.30$-0.36+16.67%Beat+49.2%
    Dec 23
    Reported Mar 5
    		$-0.40$-0.39-2.56%Miss+42.9%
    Sep 23
    Reported Nov 13
    		$-0.43$-0.44+2.27%Beat+23.2%
    Jun 23
    Reported Aug 11
    		$-0.74$-0.66-12.12%Miss-15.6%
    Mar 23
    Reported May 11
    		$-0.59$-0.70+15.71%Beat+1.7%
    Dec 22
    Reported Mar 14
    		$-0.70$-0.59-18.64%Miss+30.0%
    Sep 22
    Reported Nov 9
    		$-0.56$-0.67+16.42%Beat+98.5%
    Jun 22
    Reported Aug 11
    		$-0.64$-0.68+5.88%Beat+99.9%
    Mar 22
    Reported May 16
    		$-0.60$-0.66+9.09%Beat+99.9%
    Dec 21
    Reported Mar 31
    		$-1.00$-1.02+1.96%Beat+98.6%
    Sep 21
    Reported Dec 17
    		$-36.88$-1.60-2205.00%Miss+47.5%
    Mar 21
    Reported Jun 30
    		$-494.09$0.00N/AMiss-
    Dec 20
    Reported Mar 31
    		$-494.09$0.00N/AMiss-
    Mar 20
    Reported Jun 30
    		$-70.21$0.00N/AMiss-
    Dec 19
    Reported Mar 31
    		$-70.21$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    BetaN/AAvg VolumeN/A
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.12
    SMA 20$0.16
    SMA 50$0.26
    SMA 200$0.94
    EMA 10$0.10
    EMA 20$0.16
    EMA 50$0.28
    EMA 200$0.70

    MACD

    Line: -0.07Signal: -0.06Hist: -0.01

    ADX

    ADX: 44.1+DI: 11.0-DI: 41.3

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down96.0
    PSAR$0.11

    Bollinger Bands

    Upper Band$0.31
    Lower Band$0.02
    %B Position17926%(Upper)
    Band Width0.11

    RSI (14-Day)

    Oversold
    23.8

    Momentum Oscillators

    Stoch %K7.8
    Stoch %D6.3
    Williams %R-89.4
    ROC (10d)-77.0%
    Momentum-0.16
    CCI (20d)-128.6
    MFI (14d)75.7

    Volatility Measures

    ATR (14d)$0.03(70.6%)
    StdDev (20d)0.07
    Hist Vol336.7%(High)

    Volume Flow

    VWAP$0.05
    OBV746.0M
    AD Line394.3M
    CMF (20d)0.442

    Volume Metrics

    Avg Vol (20d)33.0M
    Vol RatioN/A
    VWMA (20d)$0.06

    Pivot Points

    R3$0.09
    R2$0.07
    R1$0.06
    Pivot Point$0.04
    S1$0.03
    S2$0.02
    S3$0.00

    Advanced Oscillators

    TSI-47.93
    Ultimate Osc29.4
    KST-584.97

    Financial Data

    QuarterSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Total Revenue$0$0$0$850,000$0$0$0$1.11M$0$0$0$0
    Cost of Revenue$230,000$234,000$227,000$219,000$205,000$214,000$211,000$201,000$194,000$187,000$174,000$190,000
    Gross Profit$-230,000$-234,000$-227,000$-219,000$-205,000$-214,000$-211,000$-201,000$-194,000$-187,000$-174,000$-190,000
    Operating Expenses$19.13M$22.94M$22.36M$26.72M$26.30M$21.32M$19.99M$27.98M$23.29M$21.66M$17.75M$20.20M
    R&D$13.74M$16.65M$16.38M$21.15M$20.18M$15.85M$14.31M$21.77M$17.66M$16.50M$11.90M$14.43M
    SG&A$5.61M$6.52M$6.21M$5.80M$6.33M$5.68M$5.89M$6.41M$5.83M$5.35M$6.02M$5.96M
    Operating Income$-19,355,000$-23,170,000$-22,584,000$-26,943,000$-26,504,000$-21,533,000$-20,197,000$-28,183,000$-23,484,000$-21,852,000$-17,924,000$-20,389,000
    Interest Income$255,000$285,000$414,000$722,000$1.07M$1.31M$1.62M$1.95M$1.71M$1.20M$1.03M$780,000
    Interest Expense$886,000$253,000$0$3.94M$0$0$0$1.29M$0$0$1.29M$3,000
    Income Before Tax$-10,042,000$-26,099,000$-22,275,000$-30,888,000$-23,806,000$-20,312,000$-19,042,000$-25,829,000$-22,118,000$-20,646,000$-16,638,000$-19,084,000
    Income Tax Expense$-1,664,000$118,000$146,000$445,000$209,000$374,000$415,000$353,000$-439,000$532,000$406,000$987,000
    Net Income$-8,378,000$-26,217,000$-22,421,000$-31,333,000$-24,015,000$-20,686,000$-19,457,000$-26,182,000$-21,679,000$-21,178,000$-17,044,000$-20,071,000
    EBITDA$-8,926,000$-25,612,000$-22,048,000$-30,669,000$-23,601,000$-20,098,000$-18,831,000$-25,628,000$-21,924,000$-20,459,000$-16,464,000$-18,894,000
    EBIT$-9,156,000$-25,846,000$-22,275,000$-30,888,000$-23,806,000$-20,312,000$-19,042,000$-25,829,000$-22,118,000$-20,646,000$-16,638,000$-19,084,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about IOBT

    News

    Price to earnings forward of IO Biotech, Inc. – OTC:IOBTQ

    This page provides financial information for IO Biotech, Inc. (OTC: IOBTQ) from TradingView, specifically focusing on its Price to Earnings (forward) metric. The content includes general market and company details, but the specific value of the Price to Earnings forward is not displayed on the page. It primarily serves as a placeholder for financial data often found on TradingView.

    TradingView•7/8/26•
    Neutral

    Price to sales forward of IO Biotech, Inc. – OTC:IOBTQ

    This article displays the forward price-to-sales ratio for IO Biotech, Inc. (OTC: IOBTQ). It also includes a period value, change, and percentage change. The content highlights financial data sourced from various providers like ICE Data Services and FactSet.

    TradingView•7/7/26•
    Neutral

    IO Biotech Inc (IOBT) Technical Analysis: Support, Resistance, Indicators & Moving Averages

    This article provides a technical analysis of IO Biotech Inc (IOBT), focusing on its indicators and moving averages. It highlights that relevant data for support and resistance have not yet been disclosed by the company. The analysis concludes with a "Sell" signal based on both moving averages and other technical indicators, showing an overall bearish outlook for the stock.

    TradingKey•6/17/26•
    Bearish

    IO Biotech Inc (IOBT) Valuation: PE, PB & Fair Value Analysis

    This article provides a brief valuation overview for IO Biotech Inc (IOBT), presenting its current market data including stock price, market cap, and pre-market activity. It highlights that key valuation metrics such as P/E, P/B, P/S, and P/CF ratios have not yet been disclosed by the company, indicating a lack of comprehensive financial data for traditional valuation analysis. The page presents a partial "TradingKey Stock Score" assessment framework, but without specific values for IO Biotech's valuation metrics.

    TradingKey•6/17/26•
    Neutral

    IO Biotech Inc (IOBT) Earnings Forecast: Future EPS & Revenue Growth Estimates

    This article provides an earnings forecast for IO Biotech Inc (IOBT), presenting current stock information, analyst price targets, and past and projected EPS figures. Analysts forecast an average price target of $3.00 for IOBT, with a high of $4.00 and a low of $0.39. The company's previous quarter's EPS was USD -0.40 against an expectation of USD -0.13, and the next quarter's EPS is projected to be USD -0.26.

    TradingKey•6/17/26•
    Neutral

    Frequently Asked Questions About IOBT

    Does IOBT pay dividends?
    IOBT (IOBT) does not currently pay a regular dividend.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In